Paper37560197
Inducible HEK293 AAV packaging cell lines expressing Rep proteins.
Jalšić L and 7 others. Mol Ther Methods Clin Dev, 2023. Cited by 22 papers, by iCite.
Cite this record
ConductScience Library. Inducible HEK293 AAV packaging cell lines expressing Rep proteins. Papers, record 37560197. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37560197
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References74
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 2545917 | Adeno-associated virus P5 promoter contains an adenovirus E1A-inducible element and a binding site for the major late transcription factor. | J Virol | 1989 | https://conductscience.org/library/papers/2545917 | PubMed |
| 2 | 15310852 | Structure of adeno-associated virus type 2 Rep40-ADP complex: insight into nucleotide recognition and catalysis by superfamily 3 helicases. | Proc Natl Acad Sci U S A | 2004 | https://conductscience.org/library/papers/15310852 | PubMed |
| 3 | 18180776 | Inducible packaging cells for large-scale production of lentiviral vectors in serum-free suspension culture. | Mol Ther | 2008 | https://conductscience.org/library/papers/18180776 | PubMed |
| 4 | 9188591 | Role for highly regulated rep gene expression in adeno-associated virus vector production. | J Virol | 1997 | https://conductscience.org/library/papers/9188591 | PubMed |
| 5 | 9696794 | Packaging cells based on inducible gene amplification for the production of adeno-associated virus vectors. | J Virol | 1998 | https://conductscience.org/library/papers/9696794 | PubMed |
| 6 | 9123860 | Characterization of the Rep78/adeno-associated virus complex. | Virology | 1997 | https://conductscience.org/library/papers/9123860 | PubMed |
| 7 | 1783673 | Antineoplastic activity of parvoviruses. | J Virol Methods | 1991 | https://conductscience.org/library/papers/1783673 | PubMed |
| 8 | 18400866 | In vitro and in vivo gene therapy vector evolution via multispecies interbreeding and retargeting of adeno-associated viruses. | J Virol | 2008 | https://conductscience.org/library/papers/18400866 | PubMed |
| 9 | 10944118 | Inhibition of S-phase progression by adeno-associated virus Rep78 protein is mediated by hypophosphorylated pRb. | EMBO J | 2000 | https://conductscience.org/library/papers/10944118 | PubMed |
| 10 | 15122043 | Separate control of Rep and Cap expression using mutant and wild-type loxP sequences and improved packaging system for adeno-associated virus vector production. | Mol Biotechnol | 2004 | https://conductscience.org/library/papers/15122043 | PubMed |
| 11 | 10953917 | Efficient recombinant adeno-associated virus production by a stable rep-cap HeLa cell line correlates with adenovirus-induced amplification of the integrated rep-cap genome. | J Gene Med | 2000 | https://conductscience.org/library/papers/10953917 | PubMed |
| 12 | 10684315 | Mutational analysis of adeno-associated virus type 2 Rep68 protein endonuclease activity on partially single-stranded substrates. | J Virol | 2000 | https://conductscience.org/library/papers/10684315 | PubMed |
| 13 | 7474103 | High-level expression of adeno-associated virus (AAV) Rep78 or Rep68 protein is sufficient for infectious-particle formation by a rep-negative AAV mutant. | J Virol | 1995 | https://conductscience.org/library/papers/7474103 | PubMed |
| 14 | 19848592 | Manufacturing recombinant adeno-associated viral vectors from producer cell clones. | Hum Gene Ther | 2009 | https://conductscience.org/library/papers/19848592 | PubMed |
| 15 | 11799185 | Feasibility of generating adeno-associated virus packaging cell lines containing inducible adenovirus helper genes. | J Virol | 2002 | https://conductscience.org/library/papers/11799185 | PubMed |
| 16 | 9217065 | Cloning and sequencing of the cellular-viral junctions from the human adenovirus type 5 transformed 293 cell line. | Virology | 1997 | https://conductscience.org/library/papers/9217065 | PubMed |
| 17 | 7636994 | Mutational analysis of adeno-associated virus Rep protein-mediated inhibition of heterologous and homologous promoters. | J Virol | 1995 | https://conductscience.org/library/papers/7636994 | PubMed |
| 18 | 15347316 | Development of packaging cell lines for generation of adeno-associated virus vectors by lentiviral gene transfer of trans-complementary components. | Eur J Haematol | 2004 | https://conductscience.org/library/papers/15347316 | PubMed |
| 19 | 22428977 | Universal real-time PCR for the detection and quantification of adeno-associated virus serotype 2-derived inverted terminal repeat sequences. | Hum Gene Ther Methods | 2012 | https://conductscience.org/library/papers/22428977 | PubMed |
| 20 | 9829534 | High-titer adeno-associated viral vectors from a Rep/Cap cell line and hybrid shuttle virus. | Hum Gene Ther | 1998 | https://conductscience.org/library/papers/9829534 | PubMed |
Cited by14
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 22 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42353252 | Comparative Analysis of rAAV Production from Plasmid-Encoded Versus Chromosomally Integrated rAAV Transgene in HEK293 Cells. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42353252 | PubMed |
| 42339583 | Status and future of recombinant adeno-associated virus vector manufacturing. | Biotechnol Prog | 2026 | https://conductscience.org/library/papers/42339583 | PubMed |
| 41321396 | Characterization of difficult-to-remove host cell proteins in adeno-associated virus downstream processing. | Mol Ther Methods Clin Dev | 2025 | https://conductscience.org/library/papers/41321396 | PubMed |
| 40737087 | Synthetic G-quadruplex components for predictable, precise two-level control of mammalian recombinant protein expression. | Nucleic Acids Res | 2025 | https://conductscience.org/library/papers/40737087 | PubMed |
| 40503174 | AAVone: A cost-effective, single-plasmid solution for efficient AAV production with reduced DNA impurities. | Mol Ther Nucleic Acids | 2025 | https://conductscience.org/library/papers/40503174 | PubMed |
| 40213384 | A two-pass anion-exchange chromatography strategy for enrichment of full capsids in manufacturing of adeno-associated viral vectors. | Mol Ther Methods Clin Dev | 2025 | https://conductscience.org/library/papers/40213384 | PubMed |
| 39968185 | Polo-like kinase inhibitors increase AAV production by halting cell cycle progression. | Mol Ther Methods Clin Dev | 2025 | https://conductscience.org/library/papers/39968185 | PubMed |
| 39230729 | Enhanced ER protein processing gene expression increases rAAV yield and full capsid ratio in HEK293 cells. | Appl Microbiol Biotechnol | 2024 | https://conductscience.org/library/papers/39230729 | PubMed |
| 39225214 | Recent Advances in Therapeutics and Manufacturing Processes of Recombinant Adeno-Associated Virus for the Treatment of Lung Diseases. | Curr Gene Ther | 2025 | https://conductscience.org/library/papers/39225214 | PubMed |
| 39194716 | Therapeutic Application and Structural Features of Adeno-Associated Virus Vector. | Curr Issues Mol Biol | 2024 | https://conductscience.org/library/papers/39194716 | PubMed |
| 38565561 | Adeno-associated virus as a delivery vector for gene therapy of human diseases. | Signal Transduct Target Ther | 2024 | https://conductscience.org/library/papers/38565561 | PubMed |
| 38543743 | Advances of Recombinant Adenoviral Vectors in Preclinical and Clinical Applications. | Viruses | 2024 | https://conductscience.org/library/papers/38543743 | PubMed |
| 38399788 | Development of Stable Packaging and Producer Cell Lines for the Production of AAV Vectors. | Microorganisms | 2024 | https://conductscience.org/library/papers/38399788 | PubMed |
| 38066084 | AAV production in stable packaging cells requires expression of adenovirus 22/33K protein to allow episomal amplification of integrated rep/cap genes. | Sci Rep | 2023 | https://conductscience.org/library/papers/38066084 | PubMed |
Genes7
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ALB | 213 | PubTator's text mining | https://conductscience.org/library/genes/213 | NCBI Gene |
| CAP2 | 10486 | PubTator's text mining | https://conductscience.org/library/genes/10486 | NCBI Gene |
| CHML | 1122 | PubTator's text mining | https://conductscience.org/library/genes/1122 | NCBI Gene |
| HHEX | 3087 | PubTator's text mining | https://conductscience.org/library/genes/3087 | NCBI Gene |
| RPLP0 | 6175 | PubTator's text mining | https://conductscience.org/library/genes/6175 | NCBI Gene |
| SNORA73A | 6080 | PubTator's text mining | https://conductscience.org/library/genes/6080 | NCBI Gene |
| SPI1 | 6688 | PubTator's text mining | https://conductscience.org/library/genes/6688 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/37560197
GET https://conductscience.org/api/papers/v1/37560197/references?page=2